Choline Chloride 75% Liquid CAS: 67-48-1
Related Insights
Japan's China Fatigue: Why Chemical Makers Are Redirecting Investment to India
Japanese chemical manufacturers are shifting investment away from China toward India after years of deepening engagement in Chinese markets. The pivot centers particularly on solar materials and reflects broader frustrations with operating conditions in China that procurement teams managing Asian supply chains must understand as sourcing patterns reshape across the region.
Sulfur and Aluminum Supply at Risk: What the Hormuz Crisis Means for Chemical Procurement
The Strait of Hormuz disruption extends beyond oil markets, affecting sulfur, aluminum, methanol and graphite that support global chemical manufacturing. Procurement teams should reassess sourcing strategies as industrial raw material risks continue to evolve.
Post‑Consumer Chemical Recovery: The Hormuz Crisis Case for Domestic Circular Feedstocks
The 2024 Hormuz crisis exposed fragilities in global feedstock supply chains, spotlighting the resilience of post‑consumer recycled chemicals. This article explores how domestic circular feedstocks reduce procurement risk, advance sustainability, and strengthen the circular economy.
PVC Supply Chain Risk: How Disruptions at a Major Gulf Petrochemical Hub Could Reshape Global Procurement
PVC buyers increasingly face supply chain risks that extend beyond simple price fluctuations. This analysis examines how prolonged disruptions at a major Gulf petrochemical hub could influence global PVC availability, sourcing strategies and procurement decisions over the coming years.
Why Brent Is $72.60 Despite Active Drone Strikes: What the June 29, 2026 Oil Market Paradox Means for Chemical Buyers
Brent crude has dropped to $72.60 despite ongoing military escalation across the Gulf. This unusual market reaction signals that supply recovery currently outweighs geopolitical risk, creating important implications for petrochemical procurement and chemical pricing in the months ahead.
Drug Shortage Risk Intelligence: June 24 Status Update
Drug shortage risk remains elevated in H2 2026 despite easing Hormuz tensions. Pharmaceutical procurement teams should prioritize safety stock updates, secondary supplier qualification, and stronger force majeure protections to secure supply continuity into 2027.
Don't miss out on our updates! Subscribe to our newsletter now
We're committed to your privacy. Tradeasia uses the information you provide to us to contact you about our relevant content, products, and services. For more information, check out our privacy policy.